Back to Search Start Over

A Study of Cecal Ligation and Puncture-Induced Sepsis in Tissue-Specific Tumor Necrosis Factor Receptor 1-Deficient Mice.

Authors :
Vandewalle J
Steeland S
Van Ryckeghem S
Eggermont M
Van Wonterghem E
Vandenbroucke RE
Libert C
Source :
Frontiers in immunology [Front Immunol] 2019 Nov 08; Vol. 10, pp. 2574. Date of Electronic Publication: 2019 Nov 08 (Print Publication: 2019).
Publication Year :
2019

Abstract

Sepsis is a complex syndrome resulting from a dysregulated immune response to an infection. Due to the high prevalence, morbidity, and mortality, there is a lot of interest in understanding pathways that play a role in sepsis, with a focus on the immune system. Tumor necrosis factor (TNF) is a pleiotropic pro-inflammatory cytokine and a master regulator of the immune system but clinical trials with TNF blockers in sepsis have failed to demonstrate significant protection. Since TNF stimulates two different receptors, TNF receptor 1 (TNFR1) and TNFR2, pan-TNF inhibition might be suboptimal since both receptors have opposite functions in polymicrobial sepsis. Therefore, we hypothesized that TNF has a dual role in sepsis, namely a mediating and a protective role, and that protection might be obtained by TNFR1-specific inhibition. We here confirmed that TNFR1 <superscript>-/-</superscript> mice are protected in the sterile endotoxemia model, whereas TNFR1 deficiency did not protect in the cecal ligation and puncture (CLP)-induced polymicrobial sepsis model. Since whole body TNFR1 blockage might be deleterious because of the antibacterial function of TNF/TNFR1 signaling, we focused on the potential devastating role of TNF/TNFR1 signaling in specific cell types. We were interested in the gut epithelium, the endothelium, and hepatocytes using conditional TNFR1 <superscript>-/-</superscript> mice, as these cell types have been shown to play a role in sepsis. However, none of these conditional knockout mice showed improved survival in the CLP model. We conclude that cell-specific targeting of TNFR1 to these cell types has no therapeutic future in septic peritonitis.<br /> (Copyright © 2019 Vandewalle, Steeland, Van Ryckeghem, Eggermont, Van Wonterghem, Vandenbroucke and Libert.)

Details

Language :
English
ISSN :
1664-3224
Volume :
10
Database :
MEDLINE
Journal :
Frontiers in immunology
Publication Type :
Academic Journal
Accession number :
31787972
Full Text :
https://doi.org/10.3389/fimmu.2019.02574